F Dx Advisors, Inc. Viatris Inc Transaction History

F Dx Advisors, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$11.27 - $13.53 $495,710 - $595,117	-43,985 Reduced 49.41%	45,036 $538,000
Q4 2023 Feb 12, 2024	SELL	$8.77 - $10.85 $358,842 - $443,949	-40,917 Reduced 31.49%	89,021 $964,000
Q3 2023 Nov 02, 2023	BUY	$9.59 - $11.35 $120,680 - $142,828	12,584 Added 10.72%	129,938 $1.28 Million
Q2 2023 Jul 17, 2023	BUY	$9.02 - $10.29 $162,405 - $185,271	18,005 Added 18.12%	117,354 $1.17 Million
Q4 2022 Feb 09, 2023	SELL	$8.72 - $11.56 $49,956 - $66,227	-5,729 Reduced 5.45%	99,349 $1.11 Million
Q3 2022 Nov 10, 2022	BUY	$8.48 - $11.13 $349,647 - $458,912	41,232 Added 64.58%	105,078 $895,000
Q2 2022 Aug 03, 2022	BUY	$9.95 - $12.27 $153,448 - $189,227	15,422 Added 31.85%	63,846 $668,000
Q1 2022 May 03, 2022	BUY	$9.81 - $15.4 $119,436 - $187,495	12,175 Added 33.59%	48,424 $527,000
Q4 2021 Feb 01, 2022	BUY	$12.09 - $14.68 $438,250 - $532,135	36,249 New	36,249 $490,000

1,143

989M

2.34M

2.21M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $9.25B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on F Dx Advisors, Inc. with notifications on news.